Skip to main content
bioXXmed AG (FRA:T5O0)
Germany flag Germany · Delayed Price · Currency is EUR
0.0220
-0.0180 (-45.00%)
At close: Dec 4, 2025

bioXXmed AG Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
--996.91-20,949-0.83--1.84
Upgrade
Depreciation & Amortization
-0.09-0.01-0.02
Upgrade
Other Operating Activities
-995.9120,9480.01-0
Upgrade
Change in Inventory
----0--
Upgrade
Change in Accounts Payable
----0.09--
Upgrade
Change in Other Net Operating Assets
-----0.16
Upgrade
Operating Cash Flow
--0.92-0.73-0.91--1.66
Upgrade
Capital Expenditures
----0--0
Upgrade
Investment in Securities
----1.5--4.8
Upgrade
Other Investing Activities
--0.29-0.50.03--
Upgrade
Investing Cash Flow
--0.29-0.5-1.47--4.8
Upgrade
Long-Term Debt Repaid
----0.12--
Upgrade
Total Debt Repaid
----0.12--
Upgrade
Net Debt Issued (Repaid)
----0.12--
Upgrade
Issuance of Common Stock
---4.38-6.02
Upgrade
Other Financing Activities
-0.85--0.04--
Upgrade
Financing Cash Flow
-0.85-4.22-6.02
Upgrade
Net Cash Flow
--0.36-1.231.84--0.44
Upgrade
Free Cash Flow
--0.92-0.73-0.91--1.66
Upgrade
Free Cash Flow Margin
--26223.88%-4194.44%-7473.42%--4613.89%
Upgrade
Free Cash Flow Per Share
--0.67-1.42-1.78--4.12
Upgrade
Cash Interest Paid
---0.04--
Upgrade
Levered Free Cash Flow
--0.47-0.52-0.67--0.96
Upgrade
Unlevered Free Cash Flow
--0.47-0.52-0.64--0.96
Upgrade
Change in Working Capital
----0.09-0.16
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.